SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-307300
Filing Date
2022-12-16
Accepted
2022-12-16 16:02:58
Documents
12
Period of Report
2022-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d428911d8k.htm   iXBRL 8-K 25531
  Complete submission text file 0001193125-22-307300.txt   142569

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agio-20221212.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20221212_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20221212_pre.xml EX-101.PRE 10801
6 EXTRACTED XBRL INSTANCE DOCUMENT d428911d8k_htm.xml XML 3230
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 221467896
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences